Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IVC/We Media Supplements For People With Disabilities Launching In Fall

This article was originally published in The Tan Sheet

Executive Summary

IVC Industries will develop a line of branded vitamins, minerals and herbals marketed to people with disabilities under an agreement with We Media, a multimedia company serving disabled Americans.

You may also be interested in...



IVC Industries

Supplement marketer announces agreement with digital media resource RNetHealth.com, whereby it will supply its branded vitamins and herbals to consumers on RNetHealth's soon-to-be-launched www.mymindandbody.com Web site. RNetHealth.com comprises the Recovery Network cable channel site, which offers programming on behavioral health issues. For the fiscal second quarter ending Jan. 31, IVC sales totaled $29.6 mil., down 3.8%, compared to $30.7 mil. in the year-ago period. Net income fell 19.5% to $458,000 in the three-month period

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel